Ryan Cole
Vermögen: 2 Mio $ am 30.09.2026
Vermögen: 2 Mio $ am 30.09.2026
Mr. Ryan Cole, CPA, is a Chief Operating Officer at Tang Capital Acquisition Corp., a Chief Operating Officer at Kezar Life Sciences, Inc. and a Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Mr. Cole was previously employed as a Senior Vice President-Operations by Odonate, Inc. and a Senior Auditor by Ernst & Young LLP.
He received his undergraduate degree from Santa Clara University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 116 144 ( 0,09 % ) | 2 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Geschäftsführer | 23.03.2026 |
| KEZAR LIFE SCIENCES, INC. | Geschäftsführer | 11.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01.05.2012 |
| ODONATE, INC. | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen